Azenta, Inc. provided earnings guidance for the full fiscal year 2024. The company expected revenue in the range of $659 million to $671 million, due to the timing of B Medical revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.87 USD | -0.92% | -1.41% | -21.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.91% | 2.74B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- AZTA Stock
- News Azenta, Inc.
- Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024